XML 24 R28.htm IDEA: XBRL DOCUMENT
v3.2.0.727

Acquisitions - Summary of Estimated Fair Values at Date of Acquisition (Detail) - USD ($) |  | 9 Months Ended |  |
--- | --- | --- | --- | ---
Mar. 03, 2015 | Jun. 30, 2015 | Sep. 30, 2014 | Sep. 30, 2013
Asset Acquisition [Line Items] |  |  |  |
Assets acquired |  | $ 24,317,951 | $ 68,538 | $ 123,191
Acquired in-process research and development - Pre-Clinical Candidates |  | 10,142,786 |  |
Assets acquired |  | $ 24,857,214 |  |
Novartis |  |  |  |
Asset Acquisition [Line Items] |  |  |  |
Acquired in-process research and development - Pre-Clinical Candidates | $ 10,142,786 |  |  |
Assets acquired | 35,000,000 |  |  |
Novartis | Patents [Member] |  |  |  |
Asset Acquisition [Line Items] |  |  |  |
Assets acquired | 21,728,334 |  |  |
Novartis | License [Member] |  |  |  |
Asset Acquisition [Line Items] |  |  |  |
Assets acquired | $ 3,128,880 |  |  |

X
- Definition The amount of purchased research and development assets that are acquired in asset acquisition have no alternative future use and are therefore written off in the period of acquisition. + References No definition available. + Details
Name: | arwr_AcquiredInProcessResearchAndDevelopment
Namespace Prefix: | arwr_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Asset acquisition. + References No definition available. + Details
Name: | arwr_AssetAcquisitionLineItems
Namespace Prefix: | arwr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, resulting from asset acquisition. + References No definition available. + Details
Name: | arwr_AssetsAcquiredFiniteLivedIntangibleAssets
Namespace Prefix: | arwr_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | arwr_AssetAcquisitionAxis=arwr_NovartisMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=arwr_LicenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |